Twenty‐five years' experience of prophylactic treatment in severe haemophilia A and B

Journal of Internal Medicine

Volumn 232, Issue 1, 1992, Pages 25-32

  NILSSON, I M ^a   BERNTORP, E ^a   LOFQVIST T ^a   PETTERSSON, H ^b  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

factor IX; factor VIII; haemophilia A; haemophilia B; haemophilic arthropathy; prophylaxis in haemophilia

Indexed keywords

BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 CONCENTRATE; BLOOD CLOTTING FACTOR 9 CONCENTRATE;

ADOLESCENT; ADULT; ARTHROPATHY; ARTICLE; CHILD; CONTROLLED STUDY; HEMOPHILIA A; HEMOPHILIA B; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SWEDEN;

EID: 0026635406     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.1992.tb00546.x     Document Type: Article

References (25)

1. Haemophilia in Sweden. VII. Incidence, treatment and prophylaxis of arthropathy and other musculoskeletal manifestations of haemophilia A and B
2. Haemophilia prophylaxis in Sweden
3. Radiologic evaluation of prophylaxis in severe haemophilia
4. Prophylactic treatment of factor VIII deficiency
5. Haemophilia prophylaxis with factor VIII concentrate
6. Prophylaxis of joint haemorrhages in haemophilia
7. A trial of prophylactic replacement therapy in haemophilia and Christmas disease
8. Die ambulante Dauer‐behandlung der Hämophilie A
9. Evaluation of prophylactic replacement therapy in haemophilia B
10. Twice weekly prophylactic therapy in haemophilia A
11. Physical condition, longevity, and social performance of Dutch haemophiliacs. 1972‐85
12. Prophylaxis with factor concentrates in preventing hemophilic arthropathy
13. A radiologic classification of hemophilic arthropathy
14. Purification of human and bovine fibrinogen
15. In‐vivo recovery of factor VIII: a comparison of one‐stage and two‐stage methods
16. Clinical application of the chromogenic assay of factor VIII in hemophilia A, and different variants of von Willebrand's disease
17. Immunosuppressive treatment in haemophiliacs with inhibitors to factor VIII and factor IX
18. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies
19. Patterns of bleeding in adolescents with severe hemophilia A
20. Antibody to a hepatitis C virus related protein among patients at high risk for hepatitis B
21. Experience with prophylactic treatment in the USA